Sepsis Alliance Summit 2024

Annual, virtual conference covering sepsis-related topics and offering RN CE Contact Hours

Description

*Over 350,000 U.S. adults killed each year.*

*The leading cause of death in U.S. hospitals.*

*Over 49 million people worldwide affected each year.*

This is sepsis.

Join us this September to learn more about how you can help better identify, diagnose, and treat this deadly condition in your practice. Mortality increases 4-9% for every hour that treatment is delayed. YOU can help save lives and limbs by staying up-to-date on current recommendations and guidelines around sepsis by joining us at the 5^th Annual Sepsis Alliance Summit.

For the first time, Sepsis Alliance Summit is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.

Are you ready to learn with us? Register today for this free, virtual conference. You’ll earn RN CE credits and improve your practice, benefiting sepsis patients.

FREE Nursing CE Credits Offered!

Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing for 9.7 contact hours, Provider Number CEP17068.

Conference Supporters:

Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:

Agenda

September 25, 2024

Time (ET)	Session Title	Presenter
10:00-10:15	Opening Remarks & The 2024 Erin Kay Flatley Spirit Award Winners	Carl Flatley, DDS, MSD Founder, Sepsis Alliance Jackie Duda Health and Travel Journalist Sepsis and Disability Advocate Julia Fraser Sepsis Survivor, Mrs. Texas
10:20-10:30	Day 1 Keynote: Advocacy and Awareness: Our Family's Journey with Sepsis and the Power of ‘Using Your Voice’	Jake Tapper Anchor and Chief Washington Correspondent, CNN Alice Tapper Student & Patient Advocate Jennifer Tapper Sepsis Alliance – Board of Directors
10:35-11:00	Recognizing the Overlooked: Identifying Features of Delayed Sepsis Diagnoses (CE Session)	Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE Director, Safe Medical Care Research Canadian Medical Protective Association Eileen Bridges, MD, CCFP, MSc, Dip Sport Med. Senior Physician Advisor, Safe Medical Care Learning Canadian Medical Protective Association
11:00-11:30	A Sepsis Documentation Journey: Memorial Hospital of Union County (Ohio) (CE Session)	Amy Stephens, MBA, RN, CPHQ, CHC Assistant Vice President of Quality and Compliance, Memorial Hospital Robin Regula, RN Clinical Quality Specialist Memorial Hospital
11:30-12:00	Track 1: Recce Pharmaceuticals Sponsored Session: New Frontiers in Sepsis and Urosepsis Treatment: Synthetic Anti-Infectives to Combat Superbugs Track 2: Abionic Sponsored Session: Rapid Sepsis Screening - Can Pancreatic Stone Protein (PSP) Enhance ED Triage?	Track 1: James Graham Managing Director & Chief Executive Officer, Recce Pharmaceuticals Track 2: Andrew Shorr, MD Section Director, Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center (MWHC) Evangelos J. Giamarellos-Bourboulis, MD, PhD Professor of Internal Medicine and Infectious Diseases, Medical School of the National and Kapodistrian University of Athens Patrick Pestalozzi, MBA Chief Executive Officer, Abionic
12:00-12:15	Break
12:15-12:45	Racial and Ethnic Disparities in Sepsis (CE Session)	Christopher F. Chesley, MD, MSCE Assistant Professor of Medicine Perelman School of Medicine at the University of Pennsylvania
12:50-1:20	Post-Intensive Care Syndrome in Survivors of Sepsis (CE Session)	Tracye Proffitt, PhD, RN, CNE Assistant Professor Virginia Commonwealth University School of Nursing
1:25-1:55	bioMérieux Sponsored Session: Comprehensive Clinical Solution Throughout the Acute Care Patient Journey	Daniel Feinstein, MD, MS, FACP, ACRP-PI Director of Pulmonary Critical Care Medicine, Novant Healthcare
1:55-2:10	Break
2:10-2:40	Neonatal Sepsis: A Global Challenge (CE Session)	Pascal Lavoie, MDCM, PhD Professor of Pediatrics University of British Columbia
2:45-3:30	Sepsis: Threat to Cardiovascular Health (CE Session)	Mitchell S. V. Elkind, MD, MS FAHA Chief Clinical Science Officer American Heart Association
3:35-3:50	Track 1: Roche Sponsored Session: Immunotherapy of Sepsis Guided by Biomarkers Track 2: Flosonics Medical Sponsored Session: Cracking SEP-1: Your Guide to Acing Fluid Administration Requirements	Track 1: Richard S. Hotchkiss, MD Professor of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine Track 2: Jaclyn Bond, MSN-LM, MBA-HM, RN Director of Nursing, Riverside University Health System
3:55-4:10	Track 1: InflaRx Sponsored Session: For Some Patients, COVID-19 Remains a Serious Threat Track 2: SeaStar Medical Sponsored Session: Pediatric Sepsis, The Unique Fallout of a Global Killer	Track 1: Bruce P. Burnett, PhD VP, Head of Medical Affairs, InflaRx Track 2: Rajit K. Basu, MD, MS, FCCM Division Chief of Critical Care Medicine Ann & Robert Lurie Children’s Hospital of Chicago
4:15-4:45	Advancing Health Equity for Sepsis Patients with Limited English Proficiency: Reducing Length of Stay and Readmissions (CE Session)	Moojan Rezvan, MBA Supervisor, Interpreter Services & Diversity Services, Providence Mission Hospital Emily Cusick, BSN, RN, CCRN Sepsis Clinical Coordinator Providence Mission Hospital
4:50-5:00	Day 1 Closing Remarks	Hannah Sass Sepsis Alliance

September 26, 2024

Time (ET)	Session Title	Presenter
10:00-10:15	Opening Remarks & Patient Experience	Hannah Sass Sepsis Alliance
10:20-10:50	Day 2 Keynote: The Changing Climate of Infectious Diseases and Sepsis (CE Session)Reducing Harm Related to Sepsis and Infections	Matthew C. Phillips, MD, PhD Clinical and Research Fellow Massachussetts General Hospital
10:55-11:25	Reducing Harm Related to Sepsis and Infections (CE Session)	David W. Bates, MD, MSc Co-Director Artificial Intelligence and Bioinformatics in the Learning Healthcare System Mass General Brigham
11:30-12:00	Track 1: Baxter Sponsored Session: Changing Landscape for Sepsis: Value-based Purchasing and The New CDC Hospital Sepsis Program Core Elements Track 2: Wolters Kluwer Sponsored Session: The Human Impact of Sepsis Identification and Management	Track 1: Pat Posa, RN, BSN, MSA, CCRN, FAAN Quality and Safety Program Manager Hospital Medicine Safety (HMS) Coordinating Center, University of Michigan Track 2: Elizabeth Tomaszewski, DNP, RN, CRNP, CNE, CCRN, ACNP-BC, ACNPC Clinical Content Manager, Lippincott Solutions, Lippincott Certification Review
12:00 - 12:15	Break
12:15-12:45	Hospital Care at Home in the Continuum of Care for Sepsis (CE Session)	Grace Jenq, MD Clinical Professor, Geriatric and Palliative Medicine; Associate Chief Clinical Officer, Post-Acute Care Services University of Michigan Medicine
12:50-1:20	Sepsis Patient Education as Quality Improvement (CE Session)	Bethany Koschel, DO Internal Medicine Physician Providence St. Vincent Internal Medicine
1:25-1:40	T2 Biosystems Sponsored Session: Advancing Sepsis Detection in ICUs: Assessing the Benefits and Integration of T2Candida in Clinical Practice	Cristian Merchan, Pharm.D., BCCCP Assistant Director of Clinical Pharmacy Services - Critical Care, Emergency and Perioperative Services NYU Langone Health
1:45-2:00	Track 1: Cytovale Sponsored Session: IntelliSep Revolutionizes Early Sepsis Detection: Real Cases and a Patient Story Track 2: Inflammatix Sponsored Session	Track 1: Hollis (Bud) O'Neal, MD Associate Professor of Medicine Louisiana State University Health Sciences Center Mark Laperouse, MD Medical Director Emergency Services Our Lady of the Lake Regional Medical Center
2:00-2:15	Break
2:15-2:45	Sepsis in the Cardiac Intensive Care Unit: Early Goal-Directed Mechanical Circulatory Support? (CE Session)	Jonathan Ludmir, MD Assistant Professor of Medicine Massachusetts General Hospital, Harvard Medical School
2:50-3:25	Earlier Recognition and Response to Critical Illness Outside the ICU (CE Session)	Frank Sebat, MS, MS, FCCM Director, Kritikus Foundation
3:30-3:55	Boston Scientific Sponsored Session: Intrarenal Pressure During Flexible Ureteroscopy	Manoj Monga, MD, FACS, FRCS Professor and Chair of Department of Urology, University of California San Diego Naeem Bhojani, MD Professor of Surgery University of Montreal Ben H. Chew, MD, MSc, FRCSC Associate Professor of Urology University of British Columbia
4:00-4:15	Use of Virtual Reality for Sepsis Recognition and Management Training (CE Session)	Matthew Zackoff, MD, MEd Assistant Professor, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center
4:20-4:30	Closing Remarks

September 27, 2024

For the first time, Sepsis Alliance is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.

Time (ET)	Session Title	Presenter
10:00-10:10	Opening Remarks and Land Acknowledgement	David Carlbom, MD Associate Professor of Medicine, Pulmonary Critical Care and Sleep Medicine University of Washington School of Medicine Medical Director, Respiratory Care Department Attending Physician, Medical and Trauma-Surgical Intensive Care Units Harborview Medical Center Katy Grainger Sepsis Survivor and Advocate
10:10-10:55	Session 1: Implementation of Pediatric Sepsis Phoenix Criteria Across the Globe: Building Equity? 10:10-10:15 Introductions 10:15-10:30 Development of the Phoenix Criteria for Sepsis and Septic Shock in Children 10:30-10:45 The Phoenix Pediatric Sepsis Definitions - Applying Them in South Africa 10:45-10:55 Panel Discussion	Moderator: Scott P. Sherry, MS, PA-C, FCCM Sepsis Program Manager, Oregon Health and Science University Doernbecher Children’s Hospital Nelson Sanchez-Pinto, MD, MBI, FAMIA Northwestern University - Feinberg School of Medicine Andrew Argent, MBBCh, MMed, MD, FRCPCH (UK)
11:00-11:55	Session 2: Challenges & Opportunities for Improving Maternal Sepsis Care 11:00-11:05 Introductions 11:05-11:18 Midwives’ role in preventing maternal and neonatal sepsis in Low- and Middle-Income Countries 11:18-11:31 Addressing Maternal Sepsis: A Large-Scale Quality Improvement Approach 11:31-11:44 Practical approaches to addressing maternal sepsis in Low-to-Middle Income Countries 11:44-11:55 Panel Discussion	Moderator: Scott P. Sherry, MS, PA-C, FCCM Sepsis Program Manager, Oregon Health and Science University Doernbecher Children’s Hospital Cathryn Ellis. BFA, MSc. PhD, RM (non-practicing) Associate Professor Emeritus University of British Columbia Elliott K. Main, MD Professor of Obstetrics and Gynecology Stanford University School of Medicine María Fernanda Escobar Vidarte, MD Chief of the Global Health Equity Unit Universidad del Valle, Cali - Colombia
12:00-12:30	Break
12:30-1:30	Session 3: Bedside Education - Teaching Providers How to Apply Best Practices 12:30-12:35 Introductions 12:35-12:53 The Hard Part - Turning Guidelines Into Practice 12:53-1:11 Transformational Leadership: People-Centered Framework to Address Antimicrobial Resistance, the Silent Tsunami! 1:11-1:25 Panel Discussion	Moderator: Rick Janik, BSN, RN, CEN, CFRN Flight Nurse, Airlift Northwest Laura Evans, MD, MSc Professor and Medical Director Critical Care, University of Washington Halima Salisu-Kabara, FWACN, MPA, RN-RM, CCRN Vice-Executive Director African Sepsis Alliance (ASA)
1:30-2:25	Session 4: Bench to Bedside: Updates in Sepsis Science 1:30-1:35 Introductions 1:35-2:20 Sepsis Research Update: Considerations for All Care Settings 2:20-2:25 Q&A	Moderator: Mary Jo Kelly DNP, ARNP-CNS, CCNS, CCRN Elizabeth Bridges PhD, RN, CCNS, FCCM, FAAN University of Washington Medical Center
2:30-3:25	Session 5: Sepsis Survivorship 2:30-2:35 Introductions 2:35-2:43 Journey to Sepsis Survivorship: Patient Perspective 2:43-2:56 Sepsis Aftercare: Improving the Lives of Sepsis Survivors 2:56-3:09 Sepsis Transition and Recover (STAR), Nurse Navigators Delivering Best Practice Post-Discharge Care 3:09-3:25 Panel Discussion	Moderator: Sybil Hoiss, RN, MN Lead, Clinical Initiatives & Innovation Critical Care BC, Provincial Health Services Authority Hailey Bain Sepsis Survivor and Patient Partner Sepsis Canada Mark E. Mikkelsen, MD, MSCE, FCCM Associate Chief Medical Officer, Critical Care University of Colorado Hospital Stephanie Taylor, MD, MS Division Chief of Hospital Medicine University of Michigan
3:30-4:00	Closing Remarks: Pulling It All Together	Fatima Sheikh, MSc Communications Assistant Sepsis Canada Katy Grainger Sepsis Survivor and Advocate

bioMérieux Sponsored Webinar: The Impact of Prioritizing Sepsis Management and Diagnostic Stewardship in the C-Suite

Product not yet rated Includes a Live Web Event on 09/17/2024 at 11:00 AM (PDT)

Content provided by bioMérieux (No CE credits offered)

Webinar Description:

Join us for a sponsored webinar on “The Impact of Prioritizing Sepsis Management and Diagnostic Stewardship in the C-Suite,” where we will delve into the critical importance of executive leadership in enhancing sepsis care. This session will explore the seven core elements of a robust sepsis program, the implementation of the 3- and 6-hour sepsis bundles, and the pivotal role of diagnostics in early detection and treatment. Attendees will gain a comprehensive understanding of current best practices and strategies, as well as a forward-looking perspective on the future of sepsis care, ensuring improved patient outcomes and operational efficiency.

No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

Webinar Sponsor:

Sepsis Alliance gratefully acknowledges the support provided by bioMérieux for this sponsored webinar.

Minkey Wungwattana, PharmD, BCIDP

Field Medical Director, U.S. Medical Affairs

bioMérieux

Minkey Wungwattana, PharmD, BCIDP, is a Field Medical Director with bioMérieux. He received his Doctor of Pharmacy degree from Purdue University in 2011 and completed his post-graduate residency training in infectious diseases at Indiana University Health in Indianapolis, IN. After the completion of residency training, he became the Antimicrobial Stewardship Program (ASP) director at Maine Medical Center in Portland, ME. He was successful at implementing rapid diagnostic platforms during his 10 years of clinical practice at Maine Health. His areas of interest include optimizing the outcomes of infectious diseases patients with limited resources, diagnostic stewardship, and myth busting outdated infectious disease dogmas.

Cytovale Sponsored Webinar: Saving Lives with Early Sepsis Detection - One Hospital’s Experience with IntelliSep

Content presented by Cytovale (No CE Credits)

Description:

Join us for a sponsored webinar featuring Cytovale’s IntelliSep sepsis test where we will talk about how this novel technology is changing the way patients are triaged in the ED, leading to faster, more accurate detection of sepsis and appropriate care. You will learn insights into what makes sepsis so challenging to diagnose and how IntelliSep can help. You will also meet leaders from Our Lady of the Lake Regional Medical Center, including Dr. Hollis O’Neal, who will share the impact that IntelliSep has had on their patients, day-to-day processes, and the organization broadly. For more information, visit our website cytovale.com.

Target Audience:

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Hollis (Bud) O'Neal, MD

Associate Professor of Medicine

Louisiana State University Health Sciences Center

Bud O’Neal, MD, is an Associate Professor of Clinical Medicine at LSU Health Sciences Center (LSUHSC) and the Medical Director of Research for Our Lady of the Lake Regional Medical Center in Baton Rouge. Dr. O’Neal graduated from Vanderbilt University with a Bachelor of Science in Molecular Biology and Computer Science, and subsequently completed medical school at the Louisiana State University Health Sciences Center in New Orleans. He completed his internal medicine residency at the Louisiana State University Health Sciences Center in Baton Rouge. He then completed Pulmonary and Critical Care Medicine training at Vanderbilt University, where he also earned a Master of Science in Clinical Investigation. Dr. O’Neal is a member of the American Thoracic Society, American Society of Microbiology, and the American Academy for the Advancement of Science. He is an active investigator in clinical trials, including industry-sponsored, NIH-funded, and investigator-initiated studies. His research interests include sepsis diagnosis and treatment.

Rob Scoggins, MD, PhD

Medical Director of Critical Care, Respiratory Therapy and Pulmonary Rehab

Kootenai Health

Nicole Voelker, RN

Our Lady of the Lake Regional Medical Center

Sepsis Alliance Symposium: Sepsis in Immunocompromised Patients

This live, virtual event, will cover critical topics related to sepsis in immunocompromised patients, including a special focus on patients with cancer and patients with HIV.

Description:

Date: August 1, 2024

Time: 12:00 - 4:00 pm ET / 9:00 am - 1:00 pm PT

While sepsis is an equal-opportunity killer impacting the sick, the well, and people of all ages, some groups are more likely to be affected. Those with a weakened immune system[1] are one of the groups more likely to be affected by sepsis. Individuals with any type of primary immune deficiency, human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS), cancer, organ transplants, or those on certain types of medications, like corticosteroids, are all considered immunocompromised.[2]

Sepsis is a leading cause of death, killing an estimated 350,000 adults each year in the U.S..[3] Immunocompromised patients are even more likely to die from sepsis. For instance, sepsis mortality amongst cancer patients is 43-55% higher than in patients who do not have cancer.[4] Immunocompromised patients may also present differently than patients who are not immunocompromised, due to a variable inflammatory response, leading to potential delays in diagnosis and treatment.[5] This creates additional complications, as the risk of mortality from sepsis increases by 4-9% for every hour treatment is delayed.[6]

It is imperative that healthcare professionals understand the unique risks that immunocompromised patients have regarding sepsis to efficiently and accurately assess and diagnose sepsis in immunocompromised patients.

To address this issue, Sepsis Alliance is hosting the 2024 Sepsis Alliance Symposium: Sepsis in Immunocompromised Patients. This live, virtual event, will cover critical topics related to sepsis in immunocompromised patients, including a special focus on patients with cancer and patients with HIV. Attendees will have access to the most up-to-date clinical knowledge and treatment recommendations for these populations. The key outcome of this half-day event is to establish the burden of sepsis in immunocompromised patients and improve clinical outcomes for immunocompromised patients affected by sepsis.

Covered topics will include:

Infection and sepsis burden and risks in the immunocompromised host;
Sepsis recognition and care considerations in the immunocompromised patient;
Sepsis and acute respiratory failure in patients with cancer;
The effect of HIV infection on the host response to bacterial sepsis;
Outcomes of patients with or without HIV infection.

Learning Objectives:

At the end of the activity, the learner should be able to:

Identify the unique risks and burden of sepsis on immunocompromised patients;
Summarize the steps to recognizing sepsis in immunocompromised patients;
Restate the signs of acute respiratory failure in patients with cancer and sepsis;
Summarize the relationship between HIV and the host response to bacterial sepsis.

Target Audience:

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Supporters:

Sepsis Alliance gratefully acknowledges the support provided by Gilead and Baxter for this symposium.

Andre Kalil, MD, MPH, FACP, FIDSA, FCCM

Professor of Medicine, Director of Transplant Infectious Diseases Program

University of Nebraska Medical Center

Andre Kalil, MD, MPH, FACP, FIDSA, FCCM, is a practicing physician, professor of medicine, and researcher at the University of Nebraska Medical Center in Omaha, Nebraska. He is the Director of the Transplant Infectious Diseases Program at the University of Nebraska and has been the principal investigator for multiple randomized controlled trials in sepsis, pneumonia, and COVID-19.

Dr. Kalil has received numerous honors and awards, including the 2021 Scientist Laureate Award. He has been a peer-reviewer and editor for major medical journals and has published over three hundred PubMed indexed scientific articles.

Jared Greenberg, MD, MSc

Associate Professor, Department of Internal Medicine; Assistant Director, Medical Intensive Care Unit

Rush University Medical Center

Jared Greenberg MD, MSc is an Associate Professor in the Division of Pulmonary and Critical Care Medicine at Rush University Medical Center in Chicago, IL. He spends most of his clinical time providing care to patients in the medical Intensive Care Unit (ICU). He has conducted multiple studies dealing with sepsis in immunocompromised hosts. Dr. Greenberg’s current research interests involve exploring novel ways to communicate with families of critically ill patients in ways that help them make informed decisions for their loved ones. He is also interested in improving the ability of clinicians to identify families who are experiencing emotional distress during and after an ICU stay and to provide support that is individualized to their needs.

May Mei-Sheng Riley, MSN, MPH, RN, ACNP, CCRN, CIC, FAPIC

Infection Control Consultant

Stanford Health Care

May Riley, MSN, MPH, RN, ACNP, CCRN, CIC, FAPIC is an Infection Control Consultant at Stanford Health Care. May has been practicing in infection control and hospital epidemiology since 2005. She has extensive nursing experience, including medical/surgical, neurosurgery, trauma, liver transplant, and critical care nursing. May holds two master's degrees, an MSN in acute care from the UCLA School of Nursing and an MPH in epidemiology from the UCLA School of Public Health. Currently, she is a doctoral student at San Jose State University.

May's influence on infection prevention and infectious disease control is profound. Her contributions extend beyond her role as a subject matter expert on the ANA/CDC Work Group for Engaging Nurses in Antibiotic Stewardship, where she was an editorial contributor to the Prevention Strategist in 2016. May's impact is also evident in her numerous publications, including articles, books, book chapters, online education modules, and presentations. Her dedication to the infection control community is commendable.

May is also a Consulting Editor for the Journal of Critical Care Nursing Clinics of North America, published by Elsevier, and a Peer Reviewer for the Journal of AORN (Association of Perioperative Registered Nurses).

Lisa Torres, MD, MS

Assistant Professor, Division of Pulmonary and Critical Care Medicine

New York Presbyterian – Weill Cornell Medical Center

Lisa Torres, MD, MS, is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at New York Presbyterian – Weill Cornell Medical Center. She earned her MD from the Royal College of Surgeons in Ireland and an MS in Clinical and Translational Investigation from Weill Cornell Graduate School of Medical Sciences. After her internship in the Irish Health Service Executive, Dr. Torres completed residency training in Internal Medicine at the University of Texas Health Science Center at Houston, followed by a Fellowship in Pulmonary and Critical Care Medicine at New York Presbyterian - Weill Cornell Medical Center.

Dr. Torres is a clinician and translational investigator studying sepsis-induced immune suppression in critically ill patients. These “immune paralyzed” patients are at highest risk for opportunistic infections and mortality. Her work is focused on understanding alterations in immune cell metabolism and impaired cell signaling associated with immune paralysis. She is supported by an NIH K23 award from the National Institute of General Medical Sciences, the Houston Methodist – Weill Cornell Medicine Pilot Award, as well as the NIH Loan Repayment Program via the National Heart, Lung, and Blood Institute. Dr. Torres attends on both the Medical Intensive Care Unit and Pulmonary Consult Services at the New York-Presbyterian Weill Cornell and Lower Manhattan Hospital campuses.

Greg Martin, MD, MSc

Director, Predictive Health Institute and Center for Health Discovery and Wellbeing; Professor of Medicine; Executive Associate Division Director Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine

Emory University School of Medicine

Greg Martin, MD, MSc, is Professor of Medicine in the Emory University School of Medicine and Associate Division Director for Critical Care at Emory University in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine. Dr. Martin conducts clinical and translational research in critically ill patients, with his primary interests being in sepsis, organ dysfunction syndromes, and acute respiratory distress syndrome. He is internationally recognized for his pioneering work in the epidemiology of critical illness and his innovative studies focused on improving patient-centered outcomes. He is the co-author of over 100 scientific articles, reviews, book chapters, editorials, and scientific abstracts, and has given lectures at institutional, national and international conferences. Dr. Martin completed his undergraduate studies at Duke University; medical school, residency and subspecialty fellowship training were completed at Vanderbilt University, and a post-graduate Master of Science in Clinical Research (MSCR) degree at Emory University.

Jacqueline Squire, MD

Assistant Professor of Medicine, Consultant in the Division of Allergy, Department of Internal Medicine

Mayo Clinic Florida

Jacqueline Squire, MD, is an Assistant Professor of Medicine and consultant in the Department of Allergy and Immunology at Mayo Clinic in Jacksonville, Florida. Dr. Squire attended medical school at the University of Miami Miller School of Medicine, completed a pediatric residency at Duke University Hospital, and a fellowship in Allergy/Immunology at USF/Johns Hopkins All Children’s Hospital. Her primary clinical and research interest is in inborn errors of immunity and secondary immunodeficiency. She has authored multiple peer-reviewed articles published in the leading allergy and immunology journals and given regional and national presentations on immunodeficiency.